Early Phase Clinical Trial Outsourcing Market

Future Market Insights

Key Insight

The early phase clinical trial outsourcing market is projected to grow from USD 9.5 billion in 2025 to USD 16.2 billion by 2035, at a CAGR of 5.5%. Phase 1 will dominate with a 45.6% market share, while regulatory services will lead the services segment with a 25.3% share.

October 03, 2025

Anurag Sharma

250 Pages

Cite this Report

Early Phase Clinical Trial Outsourcing Market

https://www.futuremarketinsights.com/reports/early-phase-clinical-trial-outsourcing-market

License

Buy Now

Summary ToC Companies

Key Players

Amgen
Astellas Pharma Inc
BlackRock
Bayer
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
F. Hoffmann-La Roche Ag

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Early Phase Clinical Trial Outsourcing Market

Key Players

Similar Industry Reports